Thomas Earl, MD
Interventional Cardiology · Bangor, MENPI 1992920508
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,769 of the $2,826 with a category attached, or 62.6%. Boston Scientific accounts for 62.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $1,635 and has fallen 94.8% since, to $86 in 2025.
Across 44 payments — averaging $64.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$403
- Abiomed$163
- Abbott$139
- Siemens Medical Solutions USA, Inc.$138
- Shockwave Medical, Inc$86
- plus $141 from 6 others
Across 53 payments — averaging $145.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$8K
What the payments were for
- Travel & lodging$1,05737%
- Food & beverage$1,76963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $1,756 |
| Medtronic | 4 | $403 |
| Abiomed | 5 | $163 |
| Abbott | 3 | $139 |
| Siemens Medical Solutions USA, Inc. | 2 | $138 |
| Shockwave Medical, Inc | 1 | $86 |
| AstraZeneca | 3 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Penumbra, Inc. | 2 | $31 |
| Corindus Inc. | 1 | $15 |
| Edwards Lifesciences | 1 | $14 |
| Cardinal Health 200 LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$998
- RESOLUTE ONYX$170
- AVVIGO Guidance System$149
- CorPath GRX$130
- Ultreon$112
How this compares
$2,826 in reported general payments places this provider in the 60th percentile of 21 interventional cardiology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 15 | $165 |
| Atorvastatin Calcium | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Bangor
- Srikanth RadhakrishnanBangor$7K
- Matthew McKayBangor$4K
- Harsh MehtaBangor$2K
- Paul Vom EigenBangor$86
- Szymon WiernekScarborough$22K
- Arun ThukkaniLewiston$8K
- Ellie MuellerAugusta$6K
- Jay ShahScarborough$5K
- Bryce EinhornLewiston$5K
- Peter HigginsLewiston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.